WHITEHAWK THERAPEUTICS, INC. Proceeds from Issuance of Unsecured Debt
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Proceeds from Issuance of Unsecured Debt of $10.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfUnsecuredDebt · last filed 2017-03-07
- WHITEHAWK THERAPEUTICS, INC. proceeds from issuance of unsecured debt for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. proceeds from issuance of unsecured debt for the quarter ending 2015-12-31 was $15.00K.
- WHITEHAWK THERAPEUTICS, INC. proceeds from issuance of unsecured debt for fiscal 2016 was $10.00K, a 71.43% decline from fiscal 2015.
- WHITEHAWK THERAPEUTICS, INC. proceeds from issuance of unsecured debt for fiscal 2015 was $35.00K, a 133.33% increase from fiscal 2014.
- WHITEHAWK THERAPEUTICS, INC. proceeds from issuance of unsecured debt for fiscal 2014 was $15.00K, a 40.00% decline from fiscal 2013.
- WHITEHAWK THERAPEUTICS, INC. proceeds from issuance of unsecured debt for fiscal 2013 was $25.00K, a 0.00% change from fiscal 2012.
| Period end | Proceeds from Issuance of Unsecured Debt 3 month | Proceeds from Issuance of Unsecured Debt 9 month | Proceeds from Issuance of Unsecured Debt 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $10.00K 10-K · filed 2017-03-07 | |
| 2016-09-30 | $10.00K 10-Q · filed 2016-11-14 | ||
| 2015-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $35.00K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $20.00K 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | $15.00K 10-K · filed 2017-03-07 | ||
| 2013-12-31 | $25.00K 10-K · filed 2017-03-07 | ||
| 2012-12-31 | $25.00K 10-K · filed 2017-03-07 | ||
| 2010-12-31 | $35.00K 10-K · filed 2017-03-07 | ||
| 2009-12-31 | $25.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |